Private Placement Memorandum (PPM)

Gefion Investments, in collaboration with our experienced securities attorney, proudly offers ready-to-use PPM templates specifically designed for global life science startups. This comprehensive resource empowers startups to efficiently prepare an initial PPM draft version early in the process, supporting a cost-efficient drafting workflow.

European BioTech

Our specialized PPM template is expertly crafted for European BioTech startups seeking to attract U.S. investment. Developed with key parameters in mind, this comprehensive resource is ideal for BioTech startups.

Assumptions*:

  • European startups

  • BioTech companies currently in pre-clinical or clinical stages

  • Facilitates capital raising from U.S. institutional investors

  • Rule 506(c) offering with contemporaneous offshore offering

  • Template contains 60+ pages (incl. Subscription Agreement) with clear guidance on how to convert the template into an issuer-specific PPM**

*/ ** Please note: It is the responsibility of the issuer—in close cooperation with the issuer’s own securities attorney—to adapt this template into an applicable, issuer-specific Private Placement Memorandum (PPM).

Sample
Buy

info@gefioninvestments.com

Chicago, Illinois, USA

Securities are offered through Finalis Securities LLC Member FINRA / SIPC.

Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck

Gefion Investments is not a registered broker-dealer, and Finalis Securities LLC and Gefion Investments are separate, unaffiliated entities. www.gefioninvestments.com is a website operated by Gefion Investments, a privately held Illinois limited liability company.

Disclaimer: This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities’ registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy, is subject to change without notice, and Gefion Investments along with Finalis Securities LLC accepts no liability for its use or to update it or keep it current.

Copyright © 2025 Gefion Investments - All Rights Reserved.